Omics Publishing Group

OMICS Publishing Group was established with the aim to provide free scientific literature for the learners and practitioners, for the long-term development and prosperity of sciences and research.
Bookmark and Share
Los Angeles, CA (prHWY.com) February 11, 2013 - OMICS Publishing Group was established with the aim to provide free scientific literature for the learners and practitioners, for the long-term development and prosperity of sciences and research. OMICS Journals cover updates on research developments in various branches of science, in the form of manuscripts submitted by renowned authors. OMICS editorial board consists of over 20,000 members.

In accordance with the Bethesda statement of Open Access and the Creative Commons license, the OMICS Publishing Group presents its journals for free access and retrieval of scientific literature. This spans across research undertaken in the fields of biology, biotechnology, medicine, genetics, pharmaceuticals, engineering and even management. Each of the articles presents a new development or advanced aspect of research and opens new horizons for its applications in various fields.

The scientific journals published by OMICS Publishing Group are reviewed by qualified peers who are entrusted with accepting or rejecting the submitted manuscripts for publication. Thus, each issue of individual journals contains genuine updates in the form of articles that fulfill the need for reference and citation by the learning community, based on clear Open Access norms. This enables students and science enthusiasts to access the journal contents pertaining to their discipline free of any cost


Website:http://omicspublishinggroup.org/

###

Tag Words: pharmaceuticals, biotechnology
Categories: Technology

Link To This Press Release:

URL HTML Code
Create Press Release
Press Release Options
About This Press Release
If you have any questions about this press release, please contact the listed publisher. Please do not contact prHWY as we cannot help you with your inquiry.